0.88 (-2.76%)
As of Nov 13, 2023
Source:
Selecta Biosciences Inc (SELB) is a a clinical-stage biotechnology company leveraging our ImmTOR® platform to develop tolerogenic therapies designed to selectively mitigate unwanted immune responses. With a proven ability to induce tolerance to highly immunogenic proteins, ImmTOR has the potential to amplify the efficacy of biologic therapies, including redosing of life-saving gene therapies, as well as restore the body's natural self-tolerance in autoimmune diseases. We have several proprietary and partnered programs in our pipeline focused on enzyme therapies, gene therapies, and autoimmune diseases.
| Country | United States |
| Headquarters | watertown, massachusetts |
| Phone Number | 617-923-1400 |
| Industry | manufacturing |
| CEO | Carsten Brunn |
| Website | www.clinicaltrials.gov |